uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Everolimus plus octreotide long-acting release (LAR) for the treatment of advanced neuroendocrine tumors (NET) associated with carcinoid syndrome (RADIANT-2): Updated overall survival results
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Endocrine Oncology.
Show others and affiliations
2013 (English)In: European Journal of Cancer, ISSN 0959-8049, E-ISSN 1879-0852, Vol. 49, no Suppl. 2, S577-S577 p.Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
2013. Vol. 49, no Suppl. 2, S577-S577 p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-212464ISI: 000326843603507OAI: oai:DiVA.org:uu-212464DiVA: diva2:678095
17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity; SEP 27-OCT 01, 2013; Amsterdam, NETHERLANDS
Available from: 2013-12-11 Created: 2013-12-10 Last updated: 2013-12-11Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Öberg, Kjell E.
By organisation
Endocrine Oncology
In the same journal
European Journal of Cancer
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 180 hits
ReferencesLink to record
Permanent link

Direct link